Metronidazole Braun 5 mg/ ml Norge - norsk - Statens legemiddelverk

metronidazole braun 5 mg/ ml

b. braun melsungen ag - metronidazol - infusjonsvæske, oppløsning - 5 mg/ ml

Metronidazol Baxter Viaflo 5 mg/ ml Norge - norsk - Statens legemiddelverk

metronidazol baxter viaflo 5 mg/ ml

baxter medical ab - metronidazol - infusjonsvæske, oppløsning - 5 mg/ ml

Metronidazol Actavis 500 mg Norge - norsk - Statens legemiddelverk

metronidazol actavis 500 mg

actavis group ptc ehf (1) - metronidazol - tablett, filmdrasjert - 500 mg

Rosazol 1 % Norge - norsk - Statens legemiddelverk

rosazol 1 %

teva b.v. - metronidazol - krem - 1 %

Flagyl 400 mg Norge - norsk - Statens legemiddelverk

flagyl 400 mg

sanofi-aventis norge (3) - metronidazol - tablett, filmdrasjert - 400 mg

Flagyl 500 mg Norge - norsk - Statens legemiddelverk

flagyl 500 mg

sanofi-aventis norge (3) - metronidazol - vagitorie - 500 mg

Rozex 0.75 % Norge - norsk - Statens legemiddelverk

rozex 0.75 %

galderma nordic ab - metronidazol - krem - 0.75 %

Rozex 0.75 % Norge - norsk - Statens legemiddelverk

rozex 0.75 %

galderma nordic ab - metronidazol - gel - 0.75 %

Zidoval 7.5 mg/ g Norge - norsk - Statens legemiddelverk

zidoval 7.5 mg/ g

viatris as - metronidazol - vaginalgel - 7.5 mg/ g

Zavicefta Den europeiske union - norsk - EMA (European Medicines Agency)

zavicefta

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakterielle midler for systemisk bruk, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.